The release of microparticles by Jurkat leukemia T cells treated with staurosporine and related kinase inhibitors to induce apoptosis

Apoptosis

Volumn 15, Issue 5, 2010, Pages 586-596

  Ullal, Anirudh J ^a,b   Pisetsky, David S ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Cyclin dependent kinase; Microparticles; Protein kinase C; Staurosporine

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 [1 (3 DIMETHYLAMINOPROPYL) 5 METHOXY 1H INDOL 3 YL] 3 (1H INDOL 3 YL)MALEIMIDE; 7 HYDROXYSTAUROSPORINE; BISINDOLYLMALEIMIDE; CYCLIN DEPENDENT KINASE INHIBITOR; LIPOCORTIN 5; OLOMOUCINE; PROTEIN KINASE C; PURVALANOL A; ROSCOVITINE; STAUROSPORINE;

APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LEUKOCYTE MICROPARTICLE; PARTICLE SIZE; PHENOTYPE; PRIORITY JOURNAL; T CELL LEUKEMIA;

ANIMALS; APOPTOSIS; CELL-DERIVED MICROPARTICLES; ENZYME INHIBITORS; FLOW CYTOMETRY; HUMANS; JURKAT CELLS; NUCLEIC ACIDS; PROTEIN KINASE C; STAUROSPORINE;

EID: 77951667959     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-010-0470-3     Document Type: Article

References (48)

1. JH Distler DS Pisetsky LC Huber JR Kalden S Gay O Distler 2005 Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases Arthritis Rheum 52 3337 3348 10.1002/art.21350 16255015 1:CAS:528:DC%2BD2MXht1KrtbfP (Pubitemid 41612200)
2. J Ratajczak M Wysoczynski F Hayek A Janowska-Wieczorek MZ Ratajczak 2006 Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication Leukemia 20 1487 1495 10.1038/sj.leu.2404296 16791265 1:CAS:528:DC%2BD28XosVSjsrk%3D (Pubitemid 44264090)
3. A Piccin WG Murphy OP Smith 2007 Circulating microparticles: pathophysiology and clinical implications Blood Rev 21 157 171 10.1016/j.blre.2006.09.001 17118501 1:CAS:528:DC%2BD2sXmt1egsL0%3D (Pubitemid 46529055)
4. I Del Conde CN Shrimpton P Thiagarajan JA Lopez 2005 Tissue-factor- bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation Blood 106 1604 1611 10.1182/blood-2004-03-1095 15741221 1:CAS:528:DC%2BD2MXps1OgsLY%3D (Pubitemid 41208572)
5. JHW Distler A Jungel LC Huber, et al. 2005 The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles Proc Natl Acad Sci USA 102 2892 2897 10.1073/pnas.0409781102 15701693 1:CAS:528:DC%2BD2MXitVSksbc%3D (Pubitemid 40299887)
6. G Chironi A Simon B Hugel, et al. 2006 Circulating leukocyte-derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects Arterioscler Thromb Vasc Biol 26 2775 2780 10.1161/01.ATV.0000249639. 36915.04 17038634 1:CAS:528:DC%2BD28XhtFymt7bJ
7. A Kalinkovich S Tavor A Avigdor, et al. 2006 Functional CXCR4-expressing microparticles and SDF-1 correlate with circulating acute myelogenous leukemia cells Cancer Res 66 11013 11020 10.1158/0008-5472.CAN-06-2006 17108140 1:CAS:528:DC%2BD2sXivVyqt7s%3D (Pubitemid 44877001)
8. M Mesri DC Altieri 1998 Endothelial cell activation by leukocyte microparticles J Immunol 161 4382 4387 9780216 1:CAS:528:DyaK1cXmsF2nu78%3D
9. MD Shah AL Bergeron JF Dong JA López 2008 Flow cytometric measurement of microparticles: pitfalls and protocol modifications Platelets 19 365 372 10.1080/09537100802054107 18791943 1:CAS:528:DC%2BD1cXhtFaisrrL
10. HA Mostefai R Andriantsitohaina MC Martínez 2008 Plasma membrane microparticles in angiogenesis: role in ischemic diseases and in cancer Physiol Res 57 311 320 18597583 1:CAS:528:DC%2BD1cXptVWgsLc%3D
11. R Pihusch B Höhnberg C Salat M Pihusch E Hiller H Kolb 2002 Platelet flow cytometric findings in patients undergoing conditioning therapy for allogeneic hematopoietic stem cell transplantation Ann Hematol 81 454 461 10.1007/s00277-002-0494-z 12224003 1:CAS:528:DC%2BD38XmvFOktLk%3D (Pubitemid 36067659)
12. JM Carr AM Dvorak HF Dvorak 1985 Circulating membrane vesicles in leukemic blood Cancer Res 45 5944 5951 4053066 1:STN:280:DyaL28%2Fisl2hsA%3D%3D
13. A Janowska-Wieczorek M Wysoczynski J Kijowski, et al. 2005 Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer Int J Cancer 113 752 760 10.1002/ijc.20657 15499615 1:CAS:528: DC%2BD2MXnvFGitg%3D%3D (Pubitemid 40101256)
14. G Hron M Kollars H Webber, et al. 2007 Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer Thromb Haemost 97 119 123 17200778 1:CAS:528:DC%2BD2sXhvVOjsLg%3D
15. D Helley E Banu A Bouziane, et al. 2009 Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy Eur Urol 56 479 485 10.1016/j.eururo.2008.06.038 18585841 1:CAS:528:DC%2BD1MXhsFentbbF
16. G Koopman CP Reutelingsperger GA Kuijten RM Keehnen ST Pals MH van Oers 1994 Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis Blood 84 1415 1420 8068938 1:CAS:528: DyaK2cXmt1GmsL4%3D
17. CF Reich III DS Pisetsky 2009 The content of DNA and RNA in microparticles released by Jurkat and HL-60 cells undergoing in vitro apoptosis Exp Cell Res 315 760 768 10.1016/j.yexcr.2008.12.014 19146850 1:CAS:528:DC%2BD1MXitFSgsLs%3D
18. CW Bell W Jiang CF Reich III DS Pisetsky 2006 The extracellular release of HMGB1 during apoptotic cell death Am J Physiol Cell Physiol 291 C1318 C1325 10.1152/ajpcell.00616.2005 16855214 1:CAS:528:DC%2BD2sXjvVyi (Pubitemid 44878603)
19. Diaz-Padilla I, Siu LL, Duran I (2009) Cyclin-dependent kinase inhibitors as potential targeted anticancer agents Invest New Drugs. doi: 10.1007/s10637-009-9236-6
20. S Lapenna A Giordano 2009 Cell cycle kinases as therapeutic targets for cancer Nat Rev Drug Discov 8 547 566 10.1038/nrd2907 19568282 1:CAS:528:DC%2BD1MXnvFans78%3D
21. JHW Distler LC Huber AJ Hueber, et al. 2005 The release of microparticles by apoptotic cells and their effects on macrophages Apoptosis 10 731 741 10.1007/s10495-005-2941-5 16133865 1:STN:280:DC%2BD2MvmsVSmuw%3D%3D (Pubitemid 41187073)
22. A Rosen L Casciola-Rosen J Ahearn 1995 Novel packages of viral and self-antigens are generated during apoptosis J Exp Med 181 1557 1561 10.1084/jem.181.4.1557 7699336 1:CAS:528:DyaK2MXkslWntLk%3D
23. J Hagmann MM Burger D Dagan 1999 Regulation of plasma membrane blebbing by the cytoskeleton J Cell Biochem 73 488 499 10.1002/(SICI)1097-4644(19990615) 73:4<488::AID-JCB7>3.0.CO;2-P 10733343 1:CAS:528:DyaK1MXjsVOlsbs%3D (Pubitemid 29256938)
24. A Gescher 2000 Staurosporine analogues-pharmacological toys or useful antitumour agents? Crit Rev Oncol Hematol 34 127 135 10.1016/S1040-8428(00) 00058-5 10799837 1:STN:280:DC%2BD3c3mtFentw%3D%3D (Pubitemid 30229921)
25. K Mizuno K Noda Y Ueda, et al. 1995 UCN-01, an anti-tumor drug, is a selective inhibitor of the conventional PKC subfamily FEBS Lett 359 259 261 10.1016/0014-5793(95)00042-8 7867810 1:CAS:528:DyaK2MXjvVemsbs%3D
26. HJ Mackay CJ Twelves 2003 Protein kinase C: a target for anticancer drugs? Endocr Relat Cancer 10 389 396 10.1677/erc.0.0100389 14503915 1:CAS:528:DC%2BD3sXpsFylu7k%3D (Pubitemid 37267557)
27. AM Senderowicz 2003 Novel small molecule cyclin-dependent kinase modulators in human clinical trials Cancer Biol Ther 2 S84 S95 14508085 1:CAS:528:DC%2BD2cXis1Kgug%3D%3D
28. EA Monaco III CM Beaman-Hall A Mathur ML Vallano 2004 Roscovitine, olomoucine, purvalanol: inducers of apoptosis in maturing cerebellar granule neurons Biochem Pharmacol 67 1947 1964 10.1016/j.bcp.2004.02.007 15130771 1:CAS:528:DC%2BD2cXjvVCju7o%3D (Pubitemid 38591383)
29. RFA Zwaal P Comfurius EM Bevers 2005 Surface exposure of phosphatidylserine in pathological cells Cell Mol Life Sci 62 971 988 10.1007/s00018-005-4527-3 15761668 1:CAS:528:DC%2BD2MXkslOls7k%3D (Pubitemid 40655614)
30. S Franz K Herrmann B Fuhrnrohr, et al. 2006 After shrinkage apoptotic cells expose internal membrane-derived epitopes on their plasma membranes Cell Death Differ 14 733 742 10.1038/sj.cdd.4402066 17170754 1:CAS:528: DC%2BD2sXjt1Sku7c%3D
31. JJ Jimenez W Jy LM Mauro C Soderland LL Horstman YS Ahn 2003 Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis Thromb Res 109 175 180 10.1016/S0049-3848(03)00064-1 12757771 1:CAS:528:DC%2BD3sXjvFekt7k%3D (Pubitemid 36712905)
32. M Biggiogera MG Bottone C Pellicciari 1998 Nuclear RNA is extruded from apoptotic cells J Histochem Cytochem 46 999 1006 9705965 1:CAS:528: DyaK1cXlvVKqsLg%3D
33. JD Lane VJ Allan PG Woodman 2005 Active relocation of chromatin and endoplasmic reticulum into blebs in late apoptotic cells J Cell Sci 118 4059 4071 10.1242/jcs.02529 16129889 1:CAS:528:DC%2BD2MXhtVOqtrzP (Pubitemid 41410287)
34. ML Coleman EA Sahai M Yeo M Bosch A Dewar MF Olson 2001 Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I Nat Cell Biol 3 339 345 10.1038/35070009 11283606 1:CAS:528:DC%2BD3MXivVygsrs%3D (Pubitemid 32288440)
35. M Sebbagh C Renvoize J Hamelin N Riche J Bertoglio J Breard 2001 Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing Nat Cell Biol 3 346 352 10.1038/35070019 11283607 1:CAS:528:DC%2BD3MXivVygsbg%3D (Pubitemid 32288441)
36. A Shiratsuchi T Mori Y Nakanishi 2002 Independence of plasma membrane blebbing from other biochemical and biological characteristics of apoptotic cells J Biochem 132 381 386 12204106 1:CAS:528:DC%2BD38XosVakurg%3D
37. F Langer B Spath K Haubold, et al. 2008 Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation Ann Hematol 87 451 457 10.1007/s00277-008-0446-3 18292996 1:CAS:528:DC%2BD1cXkvFSjtr0%3D
38. J Ratajczak K Miekus M Kucia, et al. 2006 Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery Leukemia 20 847 856 10.1038/sj.leu.2404132 16453000 1:CAS:528:DC%2BD28XjslOhsbs%3D
39. JM Garcia V Garcia C Pena, et al. 2008 Extracellular plasma RNA from colon cancer patients is confined in a vesicle-like structure and is mRNA-enriched RNA 14 1424 1432 10.1261/rna.755908 18456845 1:CAS:528: DC%2BD1cXot1amtLY%3D (Pubitemid 351872198)
40. MP Hunter N Ismail X Zhang, et al. 2008 Detection of microRNA expression in human peripheral blood microvesicles PLoS ONE 3 e3694 10.1371/journal.pone. 0003694 19002258 1:CAS:528:DC%2BD1cXhsVOkt7nM
41. M Bebawy V Combes E Lee, et al. 2009 Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells Leukemia 23 1643 1649 10.1038/leu.2009.76 19369960 1:CAS:528:DC%2BD1MXhtV2rtrjP
42. E Cocucci G Racchetti P Podini J Meldolesi 2007 Enlargeosome traffic: exocytosis triggered by various signals is followed by endocytosis, membrane shedding or both Traffic 8 742 757 10.1111/j.1600-0854.2007.00566.x 17488290 1:CAS:528:DC%2BD2sXmt1OnsLY%3D (Pubitemid 46785155)
43. B Mirnikjoo K Balasubramanian AJ Schroit 2009 Suicidal membrane repair regulates phosphatidylserine externalization during apoptosis J Biol Chem 284 22512 22516 10.1074/jbc.C109.022913 19561081 1:CAS:528:DC%2BD1MXpvFKisbo%3D
44. HG Mannherz SM Gonsior X Wu, et al. 2006 Dual effects of staurosporine on A431 and NRK cells: microfilament disassembly and uncoordinated lamellipodial activity followed by cell death Eur J Cell Biol 85 785 802 10.1016/j.ejcb.2006. 02.012 16697076 1:CAS:528:DC%2BD28XptlSntLo%3D (Pubitemid 44070572)
45. R Yang W Fu S Wang T Liu S Lin-Shiau 1997 Mechanism of the morphological changes induced by staurosporine in rat osteoblasts Calcif Tissue Int 61 68 73 10.1007/s002239900297 9192517 1:CAS:528:DyaK2sXktV2gt7w%3D (Pubitemid 27262406)
46. SJ Hotte A Oza EW Winquist, et al. 2006 Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study Ann Oncol 17 334 340 10.1093/annonc/mdj076 16284058 1:STN:280:DC%2BD28%2FjvVGltg%3D%3D (Pubitemid 43160126)
47. A Jimeno MA Rudek T Purcell, et al. 2008 Phase I and pharmacokinetic study of UCN-01 in combination with irinotecan in patients with solid tumors Cancer Chemother Pharmacol 61 423 433 10.1007/s00280-007-0485-9 17429623 1:CAS:528:DC%2BD1cXisl2ksrs%3D (Pubitemid 350275977)
48. A Stepczynska K Lauber IH Engels, et al. 2001 Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation Oncogene 20 1193 1202 10.1038/sj.onc.1204221 11313863 1:CAS:528:DC%2BD3MXit1OitLk%3D (Pubitemid 32226245)